Endpoints for multimodal clinical trials in Stage III non-small cell lung cancer (NSCLC): a consensus report
Gespeichert in:
Veröffentlicht in: | Lung cancer (Amsterdam, Netherlands) Netherlands), 1994, Vol.11, p.S11-S13 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | S13 |
---|---|
container_issue | |
container_start_page | S11 |
container_title | Lung cancer (Amsterdam, Netherlands) |
container_volume | 11 |
creator | Green, M.R. Cox, J.D. Ardizzoni, A. Arriagada, R. Bureau, G. Darwish, S. Deneffe, G. Fukuoka, M. Joseph, D. Komaki, R. Mirimanoff, R.O. Mornex, F. Palazzi, M. Pastorino, U. Pavy, J.J. Postmus, P.E. Roth, J. Rubin, P. Saijo, N. Saunders, M. Stout, R. Sutedja, T.G. Trovo, M.G. |
description | |
doi_str_mv | 10.1016/0169-5002(94)91859-7 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77810114</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0169500294918597</els_id><sourcerecordid>77810114</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-34f907416630f07e0cfbda9d7ff35e51d909418dca8e9e1ca0a40d1e45778bef3</originalsourceid><addsrcrecordid>eNp9kE1rGzEQhkVJSRy3_6ABnYJ92Hbk1VqrHAJlSRqDaQ9JzkKWRkFlV3Kk3UD_feXa5NiDPmCeeUd6CPnC4CsDtv5WlqwagNVC8qVkbSMr8YHMWCtWVVvXqzMye0cuyGXOvwGYYCDPybkQwBtYzUh_F-w--jBm6mKiw9SPfohW99T0PnhTLmPyus_UB_o46hekm82GhhiqPOi-YFi2fgov1OhgMNHFz8du2y1vqKYmhowhT5km3Mc0fiIfXYnCz6dzTp7v7566h2r768em-76tTL2WY1VzJ0Fwtl7X4EAgGLezWlrhXN1gw6wEyVlrjW5RIjMaNAfLkDdCtDt09ZxcH3P3Kb5OmEc1-Hx4qA4Yp6wKVgwyXkB-BE2KOSd0ap_8oNMfxUAdJKuDQXUwqCRX_yQrUdquTvnTbkD73nSyWuq3xzqWT755TCobj8WO9QnNqGz0_x_wF-9Li1w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77810114</pqid></control><display><type>article</type><title>Endpoints for multimodal clinical trials in Stage III non-small cell lung cancer (NSCLC): a consensus report</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Green, M.R. ; Cox, J.D. ; Ardizzoni, A. ; Arriagada, R. ; Bureau, G. ; Darwish, S. ; Deneffe, G. ; Fukuoka, M. ; Joseph, D. ; Komaki, R. ; Mirimanoff, R.O. ; Mornex, F. ; Palazzi, M. ; Pastorino, U. ; Pavy, J.J. ; Postmus, P.E. ; Roth, J. ; Rubin, P. ; Saijo, N. ; Saunders, M. ; Stout, R. ; Sutedja, T.G. ; Trovo, M.G.</creator><creatorcontrib>Green, M.R. ; Cox, J.D. ; Ardizzoni, A. ; Arriagada, R. ; Bureau, G. ; Darwish, S. ; Deneffe, G. ; Fukuoka, M. ; Joseph, D. ; Komaki, R. ; Mirimanoff, R.O. ; Mornex, F. ; Palazzi, M. ; Pastorino, U. ; Pavy, J.J. ; Postmus, P.E. ; Roth, J. ; Rubin, P. ; Saijo, N. ; Saunders, M. ; Stout, R. ; Sutedja, T.G. ; Trovo, M.G.</creatorcontrib><identifier>ISSN: 0169-5002</identifier><identifier>EISSN: 1872-8332</identifier><identifier>DOI: 10.1016/0169-5002(94)91859-7</identifier><identifier>PMID: 7704502</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Carcinoma, Non-Small-Cell Lung - therapy ; Clinical Trials as Topic ; Combined Modality Therapy ; Humans ; Lung Neoplasms - therapy ; Neoplasm Staging</subject><ispartof>Lung cancer (Amsterdam, Netherlands), 1994, Vol.11, p.S11-S13</ispartof><rights>1994</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c369t-34f907416630f07e0cfbda9d7ff35e51d909418dca8e9e1ca0a40d1e45778bef3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0169-5002(94)91859-7$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,4010,27904,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7704502$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Green, M.R.</creatorcontrib><creatorcontrib>Cox, J.D.</creatorcontrib><creatorcontrib>Ardizzoni, A.</creatorcontrib><creatorcontrib>Arriagada, R.</creatorcontrib><creatorcontrib>Bureau, G.</creatorcontrib><creatorcontrib>Darwish, S.</creatorcontrib><creatorcontrib>Deneffe, G.</creatorcontrib><creatorcontrib>Fukuoka, M.</creatorcontrib><creatorcontrib>Joseph, D.</creatorcontrib><creatorcontrib>Komaki, R.</creatorcontrib><creatorcontrib>Mirimanoff, R.O.</creatorcontrib><creatorcontrib>Mornex, F.</creatorcontrib><creatorcontrib>Palazzi, M.</creatorcontrib><creatorcontrib>Pastorino, U.</creatorcontrib><creatorcontrib>Pavy, J.J.</creatorcontrib><creatorcontrib>Postmus, P.E.</creatorcontrib><creatorcontrib>Roth, J.</creatorcontrib><creatorcontrib>Rubin, P.</creatorcontrib><creatorcontrib>Saijo, N.</creatorcontrib><creatorcontrib>Saunders, M.</creatorcontrib><creatorcontrib>Stout, R.</creatorcontrib><creatorcontrib>Sutedja, T.G.</creatorcontrib><creatorcontrib>Trovo, M.G.</creatorcontrib><title>Endpoints for multimodal clinical trials in Stage III non-small cell lung cancer (NSCLC): a consensus report</title><title>Lung cancer (Amsterdam, Netherlands)</title><addtitle>Lung Cancer</addtitle><subject>Carcinoma, Non-Small-Cell Lung - therapy</subject><subject>Clinical Trials as Topic</subject><subject>Combined Modality Therapy</subject><subject>Humans</subject><subject>Lung Neoplasms - therapy</subject><subject>Neoplasm Staging</subject><issn>0169-5002</issn><issn>1872-8332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1rGzEQhkVJSRy3_6ABnYJ92Hbk1VqrHAJlSRqDaQ9JzkKWRkFlV3Kk3UD_feXa5NiDPmCeeUd6CPnC4CsDtv5WlqwagNVC8qVkbSMr8YHMWCtWVVvXqzMye0cuyGXOvwGYYCDPybkQwBtYzUh_F-w--jBm6mKiw9SPfohW99T0PnhTLmPyus_UB_o46hekm82GhhiqPOi-YFi2fgov1OhgMNHFz8du2y1vqKYmhowhT5km3Mc0fiIfXYnCz6dzTp7v7566h2r768em-76tTL2WY1VzJ0Fwtl7X4EAgGLezWlrhXN1gw6wEyVlrjW5RIjMaNAfLkDdCtDt09ZxcH3P3Kb5OmEc1-Hx4qA4Yp6wKVgwyXkB-BE2KOSd0ap_8oNMfxUAdJKuDQXUwqCRX_yQrUdquTvnTbkD73nSyWuq3xzqWT755TCobj8WO9QnNqGz0_x_wF-9Li1w</recordid><startdate>1994</startdate><enddate>1994</enddate><creator>Green, M.R.</creator><creator>Cox, J.D.</creator><creator>Ardizzoni, A.</creator><creator>Arriagada, R.</creator><creator>Bureau, G.</creator><creator>Darwish, S.</creator><creator>Deneffe, G.</creator><creator>Fukuoka, M.</creator><creator>Joseph, D.</creator><creator>Komaki, R.</creator><creator>Mirimanoff, R.O.</creator><creator>Mornex, F.</creator><creator>Palazzi, M.</creator><creator>Pastorino, U.</creator><creator>Pavy, J.J.</creator><creator>Postmus, P.E.</creator><creator>Roth, J.</creator><creator>Rubin, P.</creator><creator>Saijo, N.</creator><creator>Saunders, M.</creator><creator>Stout, R.</creator><creator>Sutedja, T.G.</creator><creator>Trovo, M.G.</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1994</creationdate><title>Endpoints for multimodal clinical trials in Stage III non-small cell lung cancer (NSCLC): a consensus report</title><author>Green, M.R. ; Cox, J.D. ; Ardizzoni, A. ; Arriagada, R. ; Bureau, G. ; Darwish, S. ; Deneffe, G. ; Fukuoka, M. ; Joseph, D. ; Komaki, R. ; Mirimanoff, R.O. ; Mornex, F. ; Palazzi, M. ; Pastorino, U. ; Pavy, J.J. ; Postmus, P.E. ; Roth, J. ; Rubin, P. ; Saijo, N. ; Saunders, M. ; Stout, R. ; Sutedja, T.G. ; Trovo, M.G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-34f907416630f07e0cfbda9d7ff35e51d909418dca8e9e1ca0a40d1e45778bef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Carcinoma, Non-Small-Cell Lung - therapy</topic><topic>Clinical Trials as Topic</topic><topic>Combined Modality Therapy</topic><topic>Humans</topic><topic>Lung Neoplasms - therapy</topic><topic>Neoplasm Staging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Green, M.R.</creatorcontrib><creatorcontrib>Cox, J.D.</creatorcontrib><creatorcontrib>Ardizzoni, A.</creatorcontrib><creatorcontrib>Arriagada, R.</creatorcontrib><creatorcontrib>Bureau, G.</creatorcontrib><creatorcontrib>Darwish, S.</creatorcontrib><creatorcontrib>Deneffe, G.</creatorcontrib><creatorcontrib>Fukuoka, M.</creatorcontrib><creatorcontrib>Joseph, D.</creatorcontrib><creatorcontrib>Komaki, R.</creatorcontrib><creatorcontrib>Mirimanoff, R.O.</creatorcontrib><creatorcontrib>Mornex, F.</creatorcontrib><creatorcontrib>Palazzi, M.</creatorcontrib><creatorcontrib>Pastorino, U.</creatorcontrib><creatorcontrib>Pavy, J.J.</creatorcontrib><creatorcontrib>Postmus, P.E.</creatorcontrib><creatorcontrib>Roth, J.</creatorcontrib><creatorcontrib>Rubin, P.</creatorcontrib><creatorcontrib>Saijo, N.</creatorcontrib><creatorcontrib>Saunders, M.</creatorcontrib><creatorcontrib>Stout, R.</creatorcontrib><creatorcontrib>Sutedja, T.G.</creatorcontrib><creatorcontrib>Trovo, M.G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Lung cancer (Amsterdam, Netherlands)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Green, M.R.</au><au>Cox, J.D.</au><au>Ardizzoni, A.</au><au>Arriagada, R.</au><au>Bureau, G.</au><au>Darwish, S.</au><au>Deneffe, G.</au><au>Fukuoka, M.</au><au>Joseph, D.</au><au>Komaki, R.</au><au>Mirimanoff, R.O.</au><au>Mornex, F.</au><au>Palazzi, M.</au><au>Pastorino, U.</au><au>Pavy, J.J.</au><au>Postmus, P.E.</au><au>Roth, J.</au><au>Rubin, P.</au><au>Saijo, N.</au><au>Saunders, M.</au><au>Stout, R.</au><au>Sutedja, T.G.</au><au>Trovo, M.G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endpoints for multimodal clinical trials in Stage III non-small cell lung cancer (NSCLC): a consensus report</atitle><jtitle>Lung cancer (Amsterdam, Netherlands)</jtitle><addtitle>Lung Cancer</addtitle><date>1994</date><risdate>1994</risdate><volume>11</volume><spage>S11</spage><epage>S13</epage><pages>S11-S13</pages><issn>0169-5002</issn><eissn>1872-8332</eissn><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>7704502</pmid><doi>10.1016/0169-5002(94)91859-7</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0169-5002 |
ispartof | Lung cancer (Amsterdam, Netherlands), 1994, Vol.11, p.S11-S13 |
issn | 0169-5002 1872-8332 |
language | eng |
recordid | cdi_proquest_miscellaneous_77810114 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Carcinoma, Non-Small-Cell Lung - therapy Clinical Trials as Topic Combined Modality Therapy Humans Lung Neoplasms - therapy Neoplasm Staging |
title | Endpoints for multimodal clinical trials in Stage III non-small cell lung cancer (NSCLC): a consensus report |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T15%3A29%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endpoints%20for%20multimodal%20clinical%20trials%20in%20Stage%20III%20non-small%20cell%20lung%20cancer%20(NSCLC):%20a%20consensus%20report&rft.jtitle=Lung%20cancer%20(Amsterdam,%20Netherlands)&rft.au=Green,%20M.R.&rft.date=1994&rft.volume=11&rft.spage=S11&rft.epage=S13&rft.pages=S11-S13&rft.issn=0169-5002&rft.eissn=1872-8332&rft_id=info:doi/10.1016/0169-5002(94)91859-7&rft_dat=%3Cproquest_cross%3E77810114%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77810114&rft_id=info:pmid/7704502&rft_els_id=0169500294918597&rfr_iscdi=true |